Skip to content
Screener

EyePoint, Inc. EYPT Total Revenue

Total Revenue at other companies

Merck & Co. logo
Merck & Co.MRK
$16.61B+5.1%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$4.29B+16.7%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$10.79M+0.8%
Regenxbio logo
RegenxbioRGNX
$108.02M+406%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$3.05M+21,664%
HRO
HarrowHROW
$70.66M+10.9%

Segments

By geography

See full
US$35.99M
CN$851K
GB$100K

By product

See full
License And Collaboration Agreement$507K-90.5%
Product Rights Agreement$0-100%
Royalty$0

Other financials

Income statement

See full
Gross profit$9.8M-30.1%
Operating income-$97.4M-56.5%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%
Free cash flow-$63.5M+0.4%

Valuation

See full
Market cap$1.11B+51.9%
Enterprise value$1.02B+49.6%
P/S396.6×+383×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Return on equity-148.7%-13,871pp
Debt / equity0.1×0.0×
Current ratio4.5×-3.5×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: EyePoint, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335037
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Product sales, net$467$715
License and collaboration agreements5075,33364616,382
Royalty income9012,689
Total revenues5075,3331,20329,786
Operating expenses:
Cost of sales165533970
Research and development83,61455,498155,757114,072
Sales and marketing31353470

Item 1. Unaudited Financial Statements

FAQ

What is EyePoint, Inc.'s total revenue?
EyePoint, Inc. (EYPT) reported total revenue of $507K in Q2 2026.
How has EyePoint, Inc.'s total revenue changed year-over-year?
EyePoint, Inc.'s total revenue decreased by 90.5% year-over-year, from $5.33M to $507K.
What is the long-term trend for EyePoint, Inc.'s total revenue?
Over 4 years (2021 to 2025), EyePoint, Inc.'s total revenue has grown at a -4.0% compound annual growth rate (CAGR), from $36.94M to $31.37M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about EyePoint, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude